Suryaa Business Desk: Pharmaceutical company Eli Lilly has announced a partnership with the telehealth and digital healthcare platform Hims & Hers. Under this agreement, Eli Lilly’s weight loss medications will be made available to consumers directly through the online platform.
The partnership aims to provide patients with access to FDA-approved medications, addressing the high demand for weight loss drugs while preventing the distribution of counterfeit products. Patients who consult with doctors and obtain a prescription through the Hims & Hers platform will be able to purchase Eli Lilly products and have them delivered to their homes.
Market participants suggest that this model may reduce the involvement of intermediaries and potentially lower costs for patients. Eli Lilly representatives stated that this direct sales approach is intended to help control the unauthorized sale of weight loss drugs on online platforms and increase transparency in the distribution of medication through digital channels.
